Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations; with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development; and with Daiichi Sankyo Company, Limited to accelerate biomarker discovery and translational research. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
Name | Title | Since | Age |
|---|---|---|---|
| Anthony Seungwook Paek | Co-Founder & Executive Chairman | - | - |
| Beomseok Brandon Suh | CEO & Director | - | - |
| Zeongwon Kim | Independent Director | - | 58 |
| Garheng Albert Kong | Non-Executive Director | - | 51 |
| Mark S. Germain | Member of Advisory Board | 2021 | 75 |
| Young Kwang Chae | Member of Advisory Board | 2021 | - |
| Khan M. Siddiqui | Member of Advisory Board | - | 52 |
| Shu Kam Mok | Member of Advisory Board | - | 66 |
| Eliot L. Siegel | Member of Advisory Board | - | - |
| Linda Moy | Member of Advisory Board | - | - |
| Kyunghyun Cho | Member of Scientific Advisor | - | - |
| Yung-Jue Bang | Member of Advisory Board | - | - |
| Wonbock Lee | Independent Director | - | 56 |
| Joonpyo Lee | Non-Executive Director | - | 44 |